Skip to main content
. 2022 Apr 21;54(1):1112–1117. doi: 10.1080/07853890.2022.2067353

Table 1.

Patient characteristics.

  ESA (n = 704) SA (n = 357) GA (n = 23) All (n = 1084) p Value of ESA and SA
Age (years) 29.2 ± 3.6 28.8 ± 3.5 28.4 ± 4.0 29.0 ± 3.6 .14
BMI* (kg/m2) 26.9 ± 2.8 27.0 ± 3.3 26.4 ± 2.8 26.9 ± 3.0 .38
Gestational age (weeks) 39.4 ± 1.2 39.9 ± 1.2 39.1 ± 1.5 39.4 ± 1.2 .22
ARM* (n [%]) 216 (30.7) 100 (28.0) 5 (21.7) 321 (29.6) .37
Oxytocin (n [%]) 336 (47.7) 159 (44.5) 14 (60.9) 509 (47.0) .33
Causes of CS (n [%])          
 FD* 250 (35.5) 126 (35.3) 15 (65.2) 391 (36.1) 1
 RCD* 149 (21.2) 48 (13.4) 1 (4.3) 198 (18.3) .81
 ACV* 51 (7.2) 21 (5.9) 0 (0) 71 (6.6) .44
 TDAF* 64 (9.1) 16 (4.5) 0 (0) 80 (7.4) .07
 FHDS* 53 (7.5) 38 (10.6) 3 (13.0) 94 (8.7) .10
Complications (n [%])          
 Diabetes 150 (21.3) 42 (11.8) 3 (13.0) 195 (18.0) <.01
 thyroid disease 51 (7.2) 38 (10.6) 1 (4.3) 90 (8.3) .06
 Anemia 21 (3.0) 10 (2.8) 1 (4.3) 32 (3.0) .87
 hypertension 59 (8.4) 37 (10.4) 1 (4.3) 97 (8.9) .29

*BMI: Body mass index; ARM: artificial rupture of membranes; FD: foetal distress; RCD: relative cephalopelvic disproportion; FHDS: foetal head drop stagnation; ACV: acute chorionic villitis; TDAF: third degree faecal staining of amniotic fluid.